Use of 17-hydroxyprogesterone doesn't reduce rate of preterm delivery or complications in twins

In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting, in San Francisco, researchers will present findings that show that the use of the hormone 17-Hydroxyprogesterone does not reduce the rate of preterm delivery or neonatal complications in twins.

Read the whole article on Physorg

More from Physorg